S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q4 2021

Avoro Capital Advisors

Periodo: Q4 2021 Β· Depositato: 2022-02-14
Vedi su SEC EDGAR β†—
AUM
$5.88B
Valore totale del portafoglio
Posizioni
41
Titoli dichiarati
Prima Posizione
HZNP
17.1% $1.00B
Var. Trimestrali
+3 / -7
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
HZNPHORIZON THERAPEUTICS PLC$1.00B17.05%β€”β€”
17.1%
MRTXMIRATI THERAPEUTICS INC$744.5M12.67%β€”β€”
12.7%
UTHRUNITED THERAPEUTICS CORP$655.8M11.16%$216.08$555.91+157.3%
11.2%
APLSAPELLIS PHARMACEUTICALS INC$404.5M6.88%$47.28β€”
6.9%
ARGXARGENX SE$337.9M5.75%$350.19$939.68+168.3%
5.8%
SRPTSAREPTA THERAPEUTICS INC$281.4M4.79%$90.05$19.28-78.6%
4.8%
ASNDASCENDIS PHARMA$269.1M4.58%$134.53$274.50+104.0%
4.6%
BMRNBIOMARIN PHARMACEUTICAL INC$247.4M4.21%$88.35$58.99-33.2%
4.2%
FOLDAMICUS THERAPEUTICS INC$213.7M3.64%β€”β€”
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$182.3M3.10%$169.58$312.78+84.4%
3.1%
IOVAIOVANCE BIOTHERAPEUTICS INC$165.6M2.82%$19.09$4.31-77.4%
2.8%
XENEXENON PHARMACEUTICALS INC$155.7M2.65%$31.24$60.96+95.1%
2.6%
ISEEIVERIC BIO INC$121.2M2.06%β€”β€”
2.1%
MDGLMADRIGAL PHARMACEUTICALS INC$120.8M2.06%$84.74$528.10+523.2%
2.1%
XBISPDR SERIES TRUST - S&P BIOTECH$117.6M2.00%$111.25$160.46+44.2%
2.0%
ARNAARENA PHARMACEUTICALS INC$114.8M1.95%β€”β€”
1.9%
GLUEMONTE ROSA THERAPEUTICS INC$67.6M1.15%$20.42$24.21+18.6%
1.1%
KURAKURA ONCOLOGY INC$56.0M0.95%$14.00$11.10-20.7%
0.9%
ACADACADIA PHARMACEUTICALS INC$51.4M0.87%$23.34$25.97+11.3%
0.9%
SNDXSYNDAX PHARMACEUTICALS INC$47.6M0.81%$21.89$21.82-0.3%
0.8%
WHWKAADI BIOSCIENCES INC$44.2M0.75%$24.15$4.19-82.7%
0.8%
MRSNMERSANA THERAPEUTICS INC$42.3M0.72%β€”β€”
0.7%
MNKDMANNKIND CORP$38.5M0.65%$4.37$4.52+3.4%
0.7%
MRNSMARINUS PHARMACEUTICALS INC$38.4M0.65%β€”β€”
0.7%
PRAXPRAXIS PRECISION MEDICINES INC$35.1M0.60%$295.50$318.52+7.8%
0.6%
DSGNDESIGN THERAPEUTICS INC$35.0M0.60%$21.41$15.64-26.9%
0.6%
KYMRKYMERA THERAPEUTICS INC$34.9M0.59%$63.49$113.51+78.8%
0.6%
CBAYCYMABAY THERAPEUTICS INC$34.8M0.59%β€”β€”
0.6%
PMVPPMV PHARMACEUTICALS INC$33.8M0.58%$23.10$1.22-94.7%
0.6%
KRYSKRYSTAL BIOTECH INC$33.2M0.57%$69.95$375.07+436.2%
0.6%

AttivitΓ  Trimestre su Trimestre

Q4 2021 vs. Q3 2021

Nuove Posizioni (3)

TickerEmittenteNozionaleDal Deposito
XBISPDR SERIES TRUST - S&P BIOTECH$117.6M+44.2%
KRYSKRYSTAL BIOTECH INC$33.2M+436.2%
IOBTQIO BIOTECH INC$10.2M

Posizioni Chiuse (7)

TickerEmittenteNozionale
XLRNACCELERON PHARMA INC$688.4M
VRTXVERTEX PHARMACEUTICALS INC$120.4M
TRILLIUM THERAPEUTICS INC$100.1M
DCPHDECIPHERA PHARMACEUTICALS INC$36.3M
BIIBBIOGEN INC$23.8M
MRUSMERUS N V$9.9M
XLRNACCELERON PHARMA INC$0.0M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SRPTCALLSAREPTA THERAPEUTICS INC$279.2M+1462.5%-78.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$164.1M+1234.6%-77.4%
APLSAPELLIS PHARMACEUTICALS INC$403.3M+464.7%
APLSAPELLIS PHARMACEUTICALS INC$239.7M+71.1%
SRPTCALLSAREPTA THERAPEUTICS INC$0.7M+50.0%-78.6%
BMRNBIOMARIN PHARMACEUTICAL INC$102.5M+49.3%-33.2%
SNDXSYNDAX PHARMACEUTICALS INC$18.1M+40.8%-0.3%
XENEXENON PHARMACEUTICALS INC$100.0M+36.6%+95.1%

Ridotte (7)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SRPTCALLSAREPTA THERAPEUTICS INC$-228.3M-88.0%-78.6%
ARNAARENA PHARMACEUTICALS INC$-89.2M-63.9%
PMVPPMV PHARMACEUTICALS INC$-53.3M-49.9%-94.7%
DICEDICE THERAPEUTICS INC$-12.0M-29.7%
FENCFENNEC PHARMACEUTICALS INC$-10.4M-28.1%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$-8.8M-26.6%
NUVLNUVALENT INC$-3.9M-12.3%
← Torna agli Hedge Fund